Your browser doesn't support javascript.
loading
MST4 inhibits human hepatocellular carcinoma cell proliferation and induces cell cycle arrest via suppression of PI3K/AKT pathway.
Hao, Wei-Chao; Zhong, Qiu-Ling; Pang, Wen-Qian; Dian, Mei-Juan; Li, Jing; Han, Liu-Xin; Zhao, Wen-Tao; Zhang, Xiao-Ling; Xiao, Sheng-Jun; Xiao, Dong; Lin, Xiao-Lin; Jia, Jun-Shuang.
Afiliação
  • Hao WC; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Zhong QL; Institute of Comparative Medicine & Laboratory Animal Center, Southern Medical University, Guangzhou 510515, China.
  • Pang WQ; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Dian MJ; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Li J; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Han LX; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  • Zhao WT; Radiotherapy Center, the First People's Hospital of Chenzhou, Chenzhou 423000, China.
  • Zhang XL; The third people's hospital of Kunming, Kunming 650041, China.
  • Xiao SJ; Department of Medical Oncology, The Third Affiliated Hospital of Kunming Medical University (Tumour Hospital of Yunnan Province), Kunming 650118, China.
  • Xiao D; Department of Physiology, Faculty of Basic Medical Sciences, Guilin Medical University, Guilin 541004, China.
  • Lin XL; Department of Pathology, the Second Affiliated Hospital, Guilin Medical University, Guilin 541199, China.
  • Jia JS; Guangdong Provincial Key Laboratory of Cancer Immunotherapy Research and Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
J Cancer ; 11(17): 5106-5117, 2020.
Article em En | MEDLINE | ID: mdl-32742458
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China